Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues

Biochemistry

Volumn 44, Issue 47, 2005, Pages 15569-15577

  Kraetke, Oliver ^a   Holeran, Brian ^b   Berger, Hartmut ^a   Escher, Emanuel ^b   Bienert, Michael ^a   Beyermann, Michael ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINO ACIDS; CELL MEMBRANES; CROSSLINKING; MOLECULAR STRUCTURE; SIZE DETERMINATION;

CORTICOTROPIN-RELEASING; CORTICOTROPIN-RELEASING FACTOR (CRF); LIGAND C-TERMINUS; N-TERMINAL TRUNCATION; NATURAL PEPTIDE; PHOTOAFFINITY;

HORMONES;

4 BENZOYLPHENYLALANINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; GLUCAGON; PHENYLALANINE DERIVATIVE; SECRETIN; UNCLASSIFIED DRUG; UROCORTIN;

AMINO ACID ANALYSIS; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HORMONE RELEASE; HUMAN; HUMAN CELL; LIGAND BINDING; ORIENTATION; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION;

EID: 28244464442     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0507027     Document Type: Article

References (51)

1. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., and Rivier, D. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor, Nature 378, 287-292.
2. Latchman, D. S. (2002) Urocortin, Int. J. Biochem. Cell Biol. 34, 907-910.
3. Zorrilla, E. P., Schulteis, G., Ormsby, A., Klaassen, A., Ling. N., McCarthy, J. R., Koob, G. F., and De Souza, E. B. (2002) Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors, Brain Res. 952, 200-210.
4. De Souza, E. B. (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders, Psychoneuroendocrinology 20,789-819.
5. Dieterich, K. D., Lehnert, H., and De Souza, E. B. (1997) Corticotropin-releasing factor receptors: an overview. Exp. Clin. Endocrinol. Diabetes 105, 65-82.
6. Owens, M. J., and Nemeroff, C. B. (1991) Physiology and pharmacology of corticotropin-releasing factor, Pharmacol. Rev. 43, 425-473.
7. Grigoriadis, D. E., Haddach, M., Ling, N., and Saunders, J. (2001) The CRF receptor: Structure, function and potential for therapeutic intervention, Curr. Med. Chem.: Cent. Nerv. Syst. Agents 1, 63-97.
8. Hauger, R. L., Grigoriadis, D. E., Dallman, M. F., Plotsky, P. M., Vale, W. W., and Dautzenberg, F. M. (2003) International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands, Pharmacol. Rev. 55, 21-26.
9. Hillhouse, E. W., Randeva, H., Ladds, G., and Grammatopoulos, D. (2002) Corticotropin-releasing hormone receptors, Biochem. Soc. Trans. 30, 428-432.
10. Arai, M., Assil, I. Q., and Abou-Samra, A. B. (2001) Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis, Endocrinology 142, 446-454.
11. Miller, D. B., and O'Callaghan, J. P. (2002) Neuroendocrine aspects of the response to stress, Metabolism 51, 5-10.
12. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin, Science 213, 1394-1397.
13. Raffin-Sanson, M. L., de Keyzer, Y., and Bertagna, X. (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions, Eur. J. Endocrinol. 149, 79-90.
14. Perrin, M. H., Sutton, S., Bain, D. L., Berggren, W. T., and Vale, W. W. (1998) The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin, Endocrinology 139, 566-570.
15. Dautzenberg, F. M., Wille, S., Lohmann, R., and Spiess, J. (1998) Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site, Proc. Natl. Acad. Sci U.S.A. 95, 4941-4946.
16. Dautzenberg, F. M., Kilpatrick, G. J., Wille, S., and Hauger, R. L. (1999) The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile, J. Neurochem. 73, 821-829.
17. Wille, S., Sydow, S., Palchaudhuri, M. R., Spiess, J., and Dautzenberg, F. M. (1999) Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding, J. Neurochem. 72, 388-395.
18. Assil, I. Q., Qi, L. J., Arai, M., Shomali, M., and Abou-Samra, A. B. (2001) Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction, Biochemistry 40, 1187-1195.
19. Liaw, C. W., Grigoriadis, D. E., Lorang, M. T., De Souza, E. B., and Maki, R. A. (1997) Localization of agonist- and antagonist- binding domains of human corticotropin-releasing factor receptors, Mol. Endocrinol. 11, 2048-2053.
20. Hoare, S. R., Sullivan, S. K., Pahuja, A., Ling, N., Crowe, P. D., and Grigoriadis, D. E. (2003) Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands, Peptides 24, 1881-1897.
21. Perrin, M. H., and Vale, W. W. (1999) Corticotropin releasing factor receptors and their ligand family, Ann. N.Y. Acad. Sci. 885, 312-328.
22. Ruhmann, A., Bonk, I., and Kopke, A. K. (1999) High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1, Peptides 20, 1311-1319.
23. Grace, C. R., Perrin, M. H., DiGruccio, M. R., Miller, C. L., Rivier, J. E., Vale, W, W., and Riek, R. (2004) NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor, Proc. Natl. Acad. Sci. U.S.A. 101, 12836-12841.
24. Klose, J., Fechner, K., Beyermann, M., Krause, E., Wendt, N., Bienert, M., Rudolph, R., and Rothemund, S. (2005) Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions, Biochemistry 44, 1614-1623.
25. Dohlman, H. G., Caron, M. G., Strader, C. D., Amlaiky, N., and Lefkowitz, R. J. (1988) Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor, Biochemistry 27, 1813-1817.
26. Janovick, J. A., Haviv, F., Fitzpatrick, T. D., and Conn, P. M. (1993) Differential orientation of a GnRH agonist and antagonist in the pituitary GnRH receptor, Endocrinology 133, 942-945.
27. Kennedy, A. F., Mangum, K. C., Linden, J., and Wells, J. N. (1996) Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe, Mol Pharmacol 50, 789-798
28. Li, Y. M., Marnerakis, M., Stimson, E. R., and Maggio, J. E. (1995) Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists, J. Biol Chem. 270, 1213-1220.
29. Boucard, A. A., Sauve, S. S., Guillemette, G., Escher, E., and Leduc, R. (2003) Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain, Biochem. J. 370, 829-838.
30. Boucard, A. A., Wilkes, B. C., Laporte, S. A., Escher, E., Guillemette, G., and Leduc, R. (2000) Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure, Biochemistry 39, 9662-9670.
31. Behar, V., Bisello, A., Rosenblatt, M., and Chorev, M. (1999) Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking, Endocrinology 140, 4251-4261.
32. Behar, V., Bisello, A., Bitan, G., Rosenblatt, M., and Chorev, M. (2000) Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor, J. Biol. Chem. 275, 9-17.
33. Dong, M., Pinon, D. L, Cox, R. F., and Miller, L. J. (2004) Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor, J. Biol. Chem. 279, 1167-1175.
34. Dong, M., Pinon, D. L, Cox, R. F., and Miller, L. J. (2004) Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor, J. Biol. Chem. 279, 31177-31182.
35. Tan, Y. V., Couvineau, A., Van Rampelbergh, J., and Laburthe, M. (2003) Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor, J. Biol. Chem. 278, 36531-36536.
36. Tan, Y. V., Couvineau, A., and Laburthe, M. (2004) Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP, J. Biol. Chem. 279, 38889-38894.
37. Pham, V. I., and Sexton, P. M. (2004) Photoaffinity scanning in the mapping of the peptide receptor interface of class II G protein-coupled receptors, J. Pept. Sci. 10, 179-203.
38. Assil-Kishawi, I., and Abou-Samra, A. B. (2002) Sauvagine crosslinks to the second extracellular loop of the corticotropin-releasing factor type 1 receptor, J. Biol. Chem. 277, 32558-32561.
39. Beyermann, M., Fechner, K., Furkert, J., Krause, E., and Bienert, M. (1996) A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor, J. Med. Chem. 39, 3324-3330.
40. Fraker, P. J., and Speck, J. C., Jr. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a- diphrenylglycoluril, Biochem. Biophys. Res. Commun. 80, 849-857.
41. Wietfeld, D., Heinrich, N., Furkert, J., Fechner, K., Beyermann, M., Bienert, M., and Berger, H. (2004) Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells, J. Biol. Chem. 279, 38386-38394.
42. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-685.
43. Grigoriadis, D. E., and De Souza, E. B. (1989) Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation, Endocrinology 125, 1877-1888.
44. Assil, I. Q., and Abou-Samra, A. B. (2001) N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction, Am. J. Physiol. Endocrinol. Metab. 281, E1015-E1021.
45. Hoare, S. R., Sullivan, S. K., Fan, J., Khongsaly, K., and Grigoriadis, D. E. (2005) Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity, Peptides 26, 457-470.
46. Adams, A. E., Bisello, A., Chorev, M., Rosenblatt, M., and Suva, L. J. (1998) Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone, Mol. Endocrinol. 12, 1673-1683.
47. Bisello, A., Adams, A. E., Mierke, D. F., Pellegrini, M., Rosenblatt, M., Suva, L. J., and Chorev, M. (1998) Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies, J. Biol. Chem. 273, 22498-22505.
48. Dong, M., Wang, Y., Pinon, D. L, Hadac, E. M., and Miller, L. J. (1999) Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling, J. Biol. Chem. 274, 903-909.
49. Dong, M., Wang, Y., Hadac, E. M., Pinon, D. L, Holicky, E., and Miller, L. J. (1999) Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor, J. Biol. Chem. 274, 19161-19167.
50. Dong, M., Asmann, Y. W., Zang, M., Pinon, D. I., and Miller, L. J. (2000) Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor, J. Biol. Chem. 275, 26032-26039.
51. Pham, V., Wade, J. D., Purdue, B. W., and Sexton, P. M. (2004) Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor, J. Biol. Chem. 279, 6720-6729.